Document is current
Any future updates will be listed below
-
Authors
Gorski, Damian
Evans, Haley
Allison, Tyler
Barria, Carla
Harrison, Danielle
Banerjee, Victor
Mendez, Nicolas
Shahnawaz, Mohammad
Kaalund, Sanne
Folke, Jonas
Aznar, Susana
Schultz, Paul
Wang, Fei
Soto, Claudio
-
Funding
Funding for this research was provided by:
Texas Alzheimer's Research and Care Consortium
National Institutes of Health
- License Information
-
More Information
Article History
Received: 13 May 2025
Accepted: 25 August 2025
First Online: 30 September 2025
Declarations
:
: All samples were acquired from deceased, de-identified individuals with written informed consent for brain autopsy and use of materials for research purposes. All samples were obtained in accordance with the Declaration of Helsinki.
: CS is a Founder, Chief Scientific Officer, consultant and shareholder of Amprion Inc., a biotechnology company that focuses on the commercial use of seed amplification assays for high-sensitivity detection of misfolded protein aggregates involved in various neurodegenerative diseases. The University of Texas Health Science Center has licensed patents to Amprion.
